Welcome to our dedicated page for Enact Holdings SEC filings (Ticker: ACT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Analyzing a mortgage insurer's SEC filings requires understanding specialized metrics that differ from traditional insurance companies. Enact Holdings' regulatory documents reveal loss reserve methodologies, reinsurance arrangements, and risk-based capital positions that determine the company's capacity to write new business and return capital to shareholders.
Enact's 10-K annual reports detail the composition of insured loans by credit score, loan-to-value ratio, and geographic distribution. These breakdowns help investors assess concentration risk and exposure to regional housing market fluctuations. The filings also explain how the company calculates loss reserves and the assumptions underlying these estimates.
Quarterly 10-Q filings provide updates on new insurance written, policy persistency trends, and claims development. For mortgage insurers, persistency is a key profitability driver since policies that remain on the books longer generate more premium income. The filings disclose how refinancing activity and home price appreciation affect the in-force portfolio.
Form 4 insider transaction filings track when executives and directors buy or sell ACT shares. For a company whose fortunes are tied to housing market cycles, insider activity can provide signals about management's view of future conditions. Our platform highlights these transactions alongside the context of recent filings.
Proxy statements (DEF 14A) detail executive compensation structures and how they align with shareholder interests. For Enact, compensation metrics often tie to return on equity, book value growth, and capital management objectives that reflect the unique economics of mortgage insurance.
Our AI-powered summaries cut through the technical accounting specific to insurance companies, highlighting material changes in loss reserves, reinsurance capacity, and regulatory capital compliance without requiring expertise in insurance statutory reporting.
Enact Holdings, Inc. reported that one of its directors acquired 165 deferred stock units on December 11, 2025 through reinvestment of a cash dividend paid at $0.21 per share.
These deferred stock units become payable in shares of common stock one year after the director’s service as a director ends. After this transaction, the director beneficially owns 30,543.457 deferred stock units, held directly and recorded at a price of $0 per unit.
Enact Holdings, Inc. reported that one of its directors acquired 165 deferred stock units on December 11, 2025 through dividend reinvestment at $0.21 per share. These deferred stock units will be paid out in shares of common stock one year after the director’s board service ends.
After this transaction, the director beneficially owns 30,543.457 deferred stock units, held directly.
Enact Holdings, Inc. reported that one of its officers, serving as Controller, acquired additional restricted stock units (RSUs) tied to existing equity awards. The RSUs were credited on December 11, 2025 under dividend reinvestment terms connected to a quarterly cash dividend of $0.21 per share.
Each restricted stock unit is structured to settle into one share of common stock on a 1:1 basis. The affected RSU awards vest and convert to common stock in three equal annual installments, with different grants beginning on February 9, 2024, February 16, 2025, April 1, 2025, February 21, 2026, and October 1, 2026. The transactions were reported as acquisitions at a $0 exercise price, reflecting their nature as stock-based compensation rather than open-market purchases.
Enact Holdings, Inc. reported that an officer serving as EVP and Chief Risk Officer acquired additional restricted stock units on December 11, 2025. The filing shows three small additions of 16, 27 and 33 restricted stock units, each settling into one share of common stock and credited at a price of $0 under existing awards.
Footnotes explain that these extra units were issued under dividend reinvestment terms following a quarterly cash dividend of $0.21 per share paid on December 11, 2025. The related restricted stock unit awards vest in three equal annual installments beginning on February 9, 2024, February 16, 2025 and February 21, 2026.
Enact Holdings, Inc. reported an insider equity change involving one of its directors. On December 11, 2025, the director acquired 31 deferred stock units through dividend reinvestment tied to a $0.21 per share dividend. These deferred stock units are payable in shares of common stock one year after the director’s service ends. Following this transaction, the director beneficially owns 5,688.256 deferred stock units.
Enact Holdings, Inc. reported an equity award update for its EVP & Chief Operations Officer. On December 11, 2025, the officer acquired 14, 22 and 26 restricted stock units at $0 per unit under dividend reinvestment terms tied to a quarterly dividend of $0.21 per share paid on that date.
Each restricted stock unit will settle into one share of Enact common stock. The underlying grants vest and convert to common stock in three equal annual installments beginning on February 9, 2024, February 16, 2025 and February 21, 2026, respectively. After these transactions, reported restricted stock unit holdings for the three grants were 2,609, 4,006 and 4,864 units, all held directly.
Enact Holdings, Inc. disclosed that one of its directors acquired 142 deferred stock units on December 11, 2025. These deferred stock units are linked to Enact’s common stock and will be paid out in shares one year after the director’s service on the board ends.
The 142 additional units were credited under a director award agreement through dividend reinvestment from a cash dividend paid on December 11, 2025 at $0.21 per share. After this transaction, the director beneficially owns 26,492.538 deferred stock units, held directly.
Enact Holdings, Inc.'s President and CEO, who also serves as a director, received additional restricted stock units as part of existing equity awards tied to the company’s quarterly dividend.
On December 11, 2025, three groups of restricted stock units were credited in amounts of 169, 200 and 243 units, all at a price of $0, increasing the executive’s direct holdings in these awards to 31,762, 37,533 and 45,583 units, respectively. Each restricted stock unit will settle into one share of common stock when it vests.
The related awards vest in three equal annual installments, beginning on February 9, 2024, February 16, 2025 and February 21, 2026. The extra units were acquired under reinvestment terms in the award agreements, based on a quarterly dividend of $0.21 per share paid on December 11, 2025.
Enact Holdings, Inc. reported an insider equity award for one of its directors. On December 11, 2025, the director acquired 165 deferred stock units tied to Enact common stock. These units were credited at a price of $0 per unit under the director award agreement from a cash dividend paid at $0.21 per share on the same date. Following this transaction, the director beneficially owns 30,543.457 deferred stock units, which become payable in shares of common stock one year after the director’s termination of service.
Enact Holdings, Inc. reported that a director and chairperson of the board acquired additional deferred stock units linked to its common stock. On 12/11/2025, 289 deferred stock units were acquired at a price of $0.00 per unit under reinvestment terms tied to a dividend paid on that date at $0.21 per share.
After this transaction, the reporting person beneficially owns 9,012.163 deferred stock units directly. Additional deferred stock units are held indirectly, including 24,177 units through the Deborah Addesso Exempt Irrevocable Trust f/b/o Dominic dated December 28, 2021 and 20,650 units through D.J. Addesso Holdings, LLC. These deferred stock units become payable in shares of common stock one year after termination of service as a director.
FAQ
What is the current stock price of Enact Holdings (ACT)?
What is the market cap of Enact Holdings (ACT)?
